Kolabtreeを選ぶ理由

開始はすばやく簡単です。初期費用はかかりません。

サービス依頼と専門家への見積依頼は無料です。

Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。

専門家と直接連携し、必要な成果を正しく得られます。

専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。

Anna Grazia R. に連絡

連絡する

Kolabtreeを選ぶ理由

この専門家をプロジェクトに採用したいですか？見積もりを依頼無料で。

プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Anna Grazia R.に依頼

Canada

PhD, PharmD. Freelance Scientific Editor/Medical Writer with over 20+ years of experience in basic and clinical research

プロフィール概要

専門分野

サービス

Writing
Research
Consulting

Writing Medical Writing, Copywriting, General Proofreading & Editing, Translation

Research Fact Checking, Systematic Literature Review

Consulting Scientific and Technical Consulting

職務経験

Scientific and Non Scientific writer/Editor

AGReed Biomedica

7月 2021 - 現在

Lab manager, Research scientist

Fondazione Amelia Scorza/Italian Leukemia Association/Hematology Unit, Annunziata Hospital of Cosenza, Italy

5月 2009 - 5月 2021

PostdoctoralResearcher

University of Calabria

5月 2006 - 5月 2009

学歴

BSc

University of Toronto

- 現在

PhD

Università della Calabria Dipartimento di Farmacia e Scienze della Salute e della Nutrizione

- 現在

PhamD (Farmacia)

Universita della Calabria

- 現在

認定資格

認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2021). Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia . Frontiers in oncology.

(2021). TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases . American journal of hematology.

(2021). Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol . European journal of haematology.

(2021). Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials . Haematologica.

(2020). Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients . Scientific reports.

(2020). Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study . Leukemia.

Gentile, M., Morabito, F., Del Poeta, G., Mauro, F.R., Reda, G., Sportoletti, P., Laurenti, L., Coscia, M., Herishanu, Y., Recchia, A.G., et al.(2020). Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study . Leukemia.

Morabito, F., Recchia, A.G., Vigna, E., Botta, C., Skafi, M., Abu-Rayyan, M., Atrash, M., Galimberti, S., Morabito, L., Al-Janazreh, H., et al.(2020). An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma . Expert Opinion on Pharmacotherapy. 21. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 29-38.

Martino, M., Gori, M., Tripepi, G., Recchia, A.G., Cimminiello, M., Provenzano, P.F., Naso, V., Ferreri, A., Moscato, T., Console, G., et al.(2020). A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant . Annals of Hematology. 99. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 331-341.

Martino, M., Gori, M., Moscato, T., Naso, V., Ferreri, A., Provenzano, F., Loteta, B., Sanguedolce, M.C., Console, G., Dattola, A., et al.(2019). Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34<sup>+</sup> Cell and Platelet Counts . Biology of Blood and Marrow Transplantation. 25. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1586-1591.

Morabito, F., Skafi, M., Recchia, A.G., Kashkeesh, A., Hindiyeh, M., Sabatleen, A., Morabito, L., Alijanazreh, H., Hamamreh, Y., Gentile, M.(2019). Lenalidomide for the treatment of mantle cell lymphoma . Expert Opinion on Pharmacotherapy. 20. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 487-494.

Martino, M., Ferreri, A., Naso, V., Moscato, T., Loteta, B., Gentile, M., Morabito, A., Provenzano, F., Cimminiello, M., Carella, A.M., et al.(2019). The use of ibrutinib before and after allogeneic stem cell transplantation . Expert Opinion on Orphan Drugs. 7. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 171-180.

Martino, M., Rossi, M., Ferreri, A., Loteta, B., Morabito, A., Moscato, T., Console, G., Innao, V., Naso, V., Provenzano, P.F., et al.(2019). Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials . Expert Review of Hematology. 12. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 665-684.

Gentile, M., Shanafelt, T.D., Mauro, F.R., Laurenti, L., Rossi, D., Molica, S., Vincelli, I., Cutrona, G., Uccello, G., Pepe, S., et al.(2018). Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases . American Journal of Hematology. 93. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString E35-E37.

Gentile, M., Shanafelt, T.D., Reda, G., Mauro, F.R., Zirlik, K., Ciolli, S., Laurenti, L., Del Principe, M.I., Rossi, D., Di Renzo, N., et al.(2018). Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab . Leukemia. 32. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1869-1873.

Cutrona, G., Tripodo, C., Matis, S., Recchia, A.G., Massucco, C., Fabbi, M., Colombo, M., Emionite, L., Sangaletti, S., Gulino, A., et al.(2018). Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence . Science Translational Medicine. 10. (428).

Vigna, E., Petrungaro, A., Perri, A., Terzi, D., Recchia, A.G., Mendicino, F., La Russa, A., Bossio, S., De Stefano, L., Zinno, F., et al.(2018). Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies . Transfusion and Apheresis Science. 57. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 247-249.

Morabito, F., Shanafelt, T.D., Gentile, M., Reda, G., Mauro, F.R., Rossi, D., Di Renzo, N., Molica, S., Angrilli, F., Chiarenza, A., et al.(2018). Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases . American Journal of Hematology. 93. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString E216-E219.

Gentile, M., Shanafelt, T.D., Mauro, F.R., Reda, G., Rossi, D., Laurenti, L., Del Principe, M.I., Cutrona, G., Angeletti, I., Coscia, M., et al.(2018). Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment . European Journal of Haematology. 101. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 703-706.

Gentile M, Magarotto V, Offidani M, Musto P, Bringhen S, Teresa Petrucci M, Gay F, Larocca A, Uccello G, Petrungaro A, Vigna E, Greco R, Grazia Recchia A, Tripepi G, Ria R, Di Raimondo F, Palumbo A, Morabito F, American journal of hematology, 2017, vol. 92, no. 3, pp. 244-250, 2017 .

Martino M, Gori M, Pitino A, Gentile M, Dattola A, Pontari A, Vigna E, Moscato T, Recchia AG, Barilla' S, Tripepi G, Morabito F, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, 2017 .

Cutrona G, Matis S, Colombo M, Massucco C, Baio G, Valdora F, Emionite L, Fabris S, Recchia AG, Gentile M, Neumaier CE, Reverberi D, Massara R, Boccardo S, Basso L, Salvi S, Rosa F, Cilli M, Zupo S, Truini M, Leukemia, 2017, 2017 .

Gentile, M., Magarotto, V., Offidani, M., Musto, P., Bringhen, S., Teresa Petrucci, M., Gay, F., Larocca, A., Uccello, G., Petrungaro, A., et al.(2017). Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials . American Journal of Hematology. 92. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 244-250.

Martino, M., Gori, M., Pitino, A., Gentile, M., Dattola, A., Pontari, A., Vigna, E., Moscato, T., Recchia, A.G., Barilla, S., et al.(2017). Basal CD34<sup>+</sup> Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony–Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study . Biology of Blood and Marrow Transplantation. 23. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1215-1220.

Cutrona, G., Matis, S., Colombo, M., Massucco, C., Baio, G., Valdora, F., Emionite, L., Fabris, S., Recchia, A.G., Gentile, M., et al.(2017). Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: Implication for therapy . Leukemia. 31. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1894-1904.

Vigna, E., Martino, B., Bacci, F., Recchia, A.G., Mendicino, F., Morelli, R., Mauro, F.R., Musolino, C., Greco, R., Lucia, E., et al.(2017). Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib . Chemotherapy. 62. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 350-352.

Martino, M., Recchia, A.G., Console, G., Gentile, M., Cimminiello, M., Gallo, G.A., Ferreri, A., Naso, V., Irrera, G., Messina, G., et al.(2017). Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma? . Expert Opinion on Orphan Drugs. 5. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 875-887.

Petrungaro, A., Gentile, M., Mazzone, C., Greco, R., Uccello, G., Recchia, A.G., De Stefano, L., Bossio, S., Palummo, A., Morelli, R., et al.(2017). Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant . Chemotherapy. 62. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 353-356.

Gentile, M., Petrungaro, A., Uccello, G., Vigna, E., Recchia, A.G., Caruso, N., Bossio, S., De Stefano, L., Palummo, A., Storino, F., et al.(2017). Venetoclax for the treatment of chronic lymphocytic leukemia . Expert Opinion on Investigational Drugs. 26. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1307-1316.

Uccello, G., Petrungaro, A., Mazzone, C., Recchia, A.G., Greco, R., Mendicino, F., Lucia, E., Vigna, E., Morabito, F., Gentile, M.(2017). Pomalidomide in multiple myeloma . Expert Opinion on Pharmacotherapy. 18. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 133-137.

Gentile, M., Shanafelt, T.D., Cutrona, G., Molica, S., Tripepi, G., Alvarez, I., Mauro, F.R., Di Renzo, N., Di Raimondo, F., Vincelli, I., et al.(2016). A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients . Leukemia. 30. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1440-1443.

Morabito, F., Voso, M.T., Hohaus, S., Gentile, M., Vigna, E., Recchia, A.G., Iovino, L., Benedetti, E., Lo-Coco, F., Galimberti, S.(2016). Panobinostat for the treatment of acute myelogenous leukemia . Expert Opinion on Investigational Drugs. 25. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1117-1131.

Molica, S., Shanafelt, T.D., Giannarelli, D., Gentile, M., Mirabelli, R., Cutrona, G., Levato, L., Di Renzo, N., Di Raimondo, F., Musolino, C., et al.(2016). The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients . American Journal of Hematology. 91. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1090-1095.

Ronchetti, D., Manzoni, M., Agnelli, L., Vinci, C., Fabris, S., Cutrona, G., Matis, S., Colombo, M., Galletti, S., Taiana, E., et al.(2016). LncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome . Blood Cancer Journal. 6. (9).

Vigna, E., Gentile, M., Giagnuolo, G., Recchia, A.G., Bossio, S., De Stefano, L., Morelli, R., Morabito, F.(2016). Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation . Leukemia and Lymphoma. 57. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2445-2447.

Valdora, F., Cutrona, G., Matis, S., Morabito, F., Massucco, C., Emionite, L., Boccardo, S., Basso, L., Recchia, A.G., Salvi, S., et al.(2016). A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) . Clinical Immunology. 172. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 52-60.

Martino, M., Tripepi, G., Messina, G., Vincelli, I.D., Console, G., Recchia, A.G., Gentile, M., Molica, S., Morabito, F.(2016). A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy . Bone Marrow Transplantation. 51. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1197-1203.

Gentile, M., Martino, M., Recchia, A.G., Vigna, E., Morabito, L., Morabito, F.(2016). Sorafenib for the treatment of multiple myeloma . Expert Opinion on Investigational Drugs. 25. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 743-749.

Martino, M., Recchia, A.G., Fedele, R., Neri, S., Vincelli, I.D., Moscato, T., Gentile, M., Morabito, F.(2016). The role of tandem stem cell transplantation for multiple myeloma patients . Expert Opinion on Biological Therapy. 16. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 515-534.

Gentile, M., Shanafelt, T.D., Rossi, D., Laurenti, L., Mauro, F.R., Molica, S., Cutrona, G., Uccello, G., Campanelli, M., Vigna, E., et al.(2016). Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients . Blood. 128. (16). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2093-2095.

Gentile, M., Vigna, E., Recchia, A.G., Morabito, L., Mendicino, F., Giagnuolo, G., Morabito, F.(2015). Bendamustine in multiple myeloma . European Journal of Haematology. 95. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 377-388.

Recchia, A.G., Caruso, N., Bossio, S., Pellicanò, M., De Stefano, L., Franzese, S., Palummo, A., Abbadessa, V., Lucia, E., Gentile, M., et al.(2015). Flow cytometric immunobead assay for detection of BCR-ABL1 fusion proteins in chronic myleoid leukemia: Comparison with FISH and PCR techniques . PLoS ONE. 10. (6).

Gentile, M., Offidani, M., Vigna, E., Corvatta, L., Recchia, A.G., Morabito, L., Morabito, F., Gentili, S.(2015). Ixazomib for the treatment of multiple myeloma . Expert Opinion on Investigational Drugs. 24. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1287-1298.

Martino, M., Bonizzoni, E., Moscato, T., Recchia, A.G., Fedele, R., Gallo, G.A., Console, G., Messina, G., Morabito, F.(2015). Mobilization of hematopoietic stem cells with lenograstim in healthy donors: Efficacy and safety analysis according to donor age . Biology of Blood and Marrow Transplantation. 21. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 881-888.

Martino, M., Recchia, A.G., Moscato, T., Fedele, R., Neri, S., Gentile, M., Alati, C., Vincelli, I.D., Piro, E., Penna, G., et al.(2015). Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients . Cytotherapy. 17. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1485-1493.

Fedele, R., Martino, M., Recchia, A.G., Irrera, G., Gentile, M., Morabito, F.(2015). Clinical options in relapsed or refractory hodgkin lymphoma: An updated review . Journal of Immunology Research. 2015.

Morabito, F., Recchia, A.G., Vigna, E., De Stefano, L., Bossio, S., Morabito, L., Pellicanò, M., Palummo, A., Storino, F., Caruso, N., et al.(2015). Promising therapies for the treatment of chronic lymphocytic leukemia . Expert Opinion on Investigational Drugs. 24. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 795-807.

Gentile, M., Offidani, M., Vigna, E., Corvatta, L., Recchia, A.G., Morabito, L., Martino, M., Morabito, F., Gentili, S.(2015). Smoldering multiple myeloma: To treat or not to treat . Expert Opinion on Pharmacotherapy. 16. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 785-790.

Maura, F., Mosca, L., Fabris, S., Cutrona, G., Matis, S., Lionetti, M., Agnelli, L., Barbieri, M., D'Anca, M., Manzoni, M., et al.(2015). Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia . PLoS ONE. 10. (3).

Morabito, F., Cutrona, G., Gentile, M., Fabris, S., Matis, S., Vigna, E., Todoerti, K., Colombo, M., Recchia, A.G., Bossio, S., et al.(2015). Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study . British Journal of Haematology. 168. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 455-459.

Morabito, F., Cutrona, G., Mosca, L., D'Anca, M., Matis, S., Gentile, M., Vigna, E., Colombo, M., Recchia, A.G., Bossio, S., et al.(2015). Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment . Leukemia Research. 39. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 840-845.

Maura, F., Cutrona, G., Mosca, L., Matis, S., Lionetti, M., Fabris, S., Agnelli, L., Colombo, M., Massucco, C., Ferracin, M., et al.(2015). Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia . Leukemia and Lymphoma. 56. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3150-3158.

Negrini, M., Cutrona, G., Bassi, C., Fabris, S., Zagatti, B., Colombo, M., Ferracin, M., D'Abundo, L., Saccenti, E., Matis, S., et al.(2014). MicroRNAome expression in chronic lymphocytic leukemia: Comparison with normal B-cell subsets and correlations with prognostic and clinical parameters . Clinical Cancer Research. 20. (15). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4141-4153.

Ronchetti, D., Tuana, G., Rinaldi, A., Agnelli, L., Cutrona, G., Mosca, L., Fabris, S., Matis, S., Colombo, M., Gentile, M., et al.(2014). Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia . Genes Chromosomes and Cancer. 53. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 264-273.

Rossi, M., Gentile, M., Toscano, R., Recchia, A.G., Bossio, S., Caruso, N., De Stefano, L., Granata, T., Pellicanò, M., Vigna, E., et al.(2014). Enumeration of interleukin-10-positive B cells from peripheral blood of patients with chronic lymphocytic leukemia . Leukemia and Lymphoma. 55. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1394-1396.

Vigna, E., Recchia, A.G., Cuzzola, M., Morabito, L., Gentile, M., Morabito, F.(2014). Erythroid but not cytogenetic response in a case with 5q- syndrome: A delayed effect of lenalidomide or a consequence of deferasirox treatment? . Leukemia and Lymphoma. 55. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1408-1409.

Gentile, M., Guido, M., Lucia, E., Vigna, E., Mazzone, C., Recchia, A.G., Morabito, F.(2014). Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib . Leukemia and Lymphoma. 55. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 709-710.

Gentile, M., Mauro, F.R., Rossi, D., Vincelli, I., Tripepi, G., Recchia, A.G., De Stefano, L., Campanelli, M., Giannarelli, D., Bossio, S., et al.(2014). Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: Analysis of 1502 cases . British Journal of Haematology. 167. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 224-232.

Gentile, M., Vigna, E., Recchia, A.G., Morabito, L., Martino, M., Morabito, F.(2014). Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patients . Expert Opinion on Pharmacotherapy. 15. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1315-1320.

Lionetti, M., Fabris, S., Cutrona, G., Agnelli, L., Ciardullo, C., Matis, S., Ciceri, G., Colombo, M., Maura, F., Mosca, L., et al.(2014). High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: Biological and clinical implications . British Journal of Haematology. 165. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 629-639.

Hoxha, M., Fabris, S., Agnelli, L., Bollati, V., Cutrona, G., Matis, S., Recchia, A.G., Gentile, M., Cortelezzi, A., Morabito, F., et al.(2014). Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia . Genes Chromosomes and Cancer. 53. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 612-621.

Martino, M., Recchia, A.G., Gentile, M., Morabito, L., Vigna, E., Cuzzola, M., Morabito, F.(2013). Diagnostic approaches for identifying acute graft-versus-host disease: What comes next? . Immunotherapy. 5. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 553-556.

Fabris, S., Mosca, L., Cutrona, G., Lionetti, M., Agnelli, L., Ciceri, G., Barbieri, M., Maura, F., Matis, S., Colombo, M., et al.(2013). Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia . American Journal of Hematology. 88. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 24-31.

Ronchetti, D., Mosca, L., Cutrona, G., Tuana, G., Gentile, M., Fabris, S., Agnelli, L., Ciceri, G., Matis, S., Massucco, C., et al.(2013). Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia . BMC Medical Genomics. 6. (1).

Gentile, M., Cutrona, G., Fabris, S., Pesce, E.A., Baldini, L., Di Raimondo, F., Musolino, C., Di Tonno, P., Di Renzo, N., Molica, S., et al.(2013). Total body computed tomography scan in the initial work-up of Binet stage a chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study . American Journal of Hematology. 88. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 539-544.

Gentile, M., Recchia, A.G., Mazzone, C., Lucia, E., Vigna, E., Morabito, F.(2013). Perspectives in the treatment of multiple myeloma . Expert Opinion on Biological Therapy. 13. (SUPPL.1).

Gentile, M., Recchia, A.G., Mazzone, C., Vigna, E., Martino, M., Morabito, L., Lucia, E., Bossio, S., De Stefano, L., Granata, T., et al.(2013). An old drug with a new future: Bendamustine in multiple myeloma . Expert Opinion on Pharmacotherapy. 14. (16). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2263-2280.

Morabito, F., Mosca, L., Cutrona, G., Agnelli, L., Tuana, G., Ferracin, M., Zagatti, B., Lionetti, M., Fabris, S., Maura, F., et al.(2013). Clinical monoclonal B lymphocytosis versus rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features . Clinical Cancer Research. 19. (21). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 5890-5900.

Cuzzola, M., Fiasché, M., Iacopino, P., Messina, G., Martino, M., Console, G., Fedele, R., Massi, D., Recchia, A.G., Irrera, G., et al.(2012). A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease . Haematologica. 97. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1532-1538.

Gentile, M., Recchia, A.G., Mazzone, C., Morabito, F.(2012). Emerging biological insights and novel treatment strategies in multiple myeloma . Expert Opinion on Emerging Drugs. 17. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 407-438.

Martino, M., Fedele, R., Massara, E., Recchia, A.G., Irrera, G., Morabito, F.(2012). Long-term safety of granulocyte colony-stimulating factor in normal donors: Is it all clear? . Expert Opinion on Biological Therapy. 12. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 609-621.

Bruno, S., Ghiotto, F., Tenca, C., Mazzarello, A.N., Bono, M., Luzzi, P., Casciaro, S., Recchia, A., Decensi, A., Morabito, F., et al.(2012). N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity . Leukemia. 26. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2260-2268.

Morabito, F., Recchia, A.G., Mazzone, C., Gentile, M.(2012). Targeted therapy of multiple myeloma: The changing paradigm at the beginning of the new millennium . Current Cancer Drug Targets. 12. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 743-756.

Recchia AG, De Francesco EM, Vivacqua A, Sisci D, Panno ML, Andò S, Maggiolini M, The Journal of biological chemistry, 2011, vol. 286, no. 12, pp. 10773-10782, 2011 .

Lappano R, Recchia AG, De Francesco EM, Angelone T, Cerra MC, Picard D, Maggiolini M, PloS one, 2011, vol. 6, no. 1, pp. e16631, 2011 .

Recchia, A.G., De Francesco, E.M., Vivacqua, A., Sisci, D., Panno, M.L., Ando, S., Maggiolini, M.(2011). The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1α (HIF-1α) in breast cancer cells and cardiomyocytes . Journal of Biological Chemistry. 286. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 10773-10782.

Vigna, E., Recchia, A.G., Madeo, A., Gentile, M., Bossio, S., Mazzone, C., Lucia, E., Morabito, L., Gigliotti, V., Stefano, L.D., et al.(2011). Epigenetic regulation in myelodysplastic syndromes: Implications for therapy . Expert Opinion on Investigational Drugs. 20. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 465-493.

Lappano, R., Recchia, A.G., de Francesco, E.M., Angelone, T., Cerra, M.C., Picard, D., Maggiolini, M.(2011). The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor α-Mediated signaling in cancer cells and in cardiomyocytes . PLoS ONE. 6. (1).

Maura, F., Cutrona, G., Fabris, S., Colombo, M., Tuana, G., Agnelli, L., Matis, S., Lionetti, M., Gentile, M., Recchia, A.G., et al.(2011). Relevance of stereotyped b-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia . PLoS ONE. 6. (8).

Morabito, F., De Filippi, R., Laurenti, L., Zirlik, K., Recchia, A.G., Gentile, M., Morelli, E., Vigna, E., Gigliotti, V., Calemma, R., et al.(2011). The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia . Blood. 118. (24). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 6353-6361.

Fabris, S., Bollati, V., Agnelli, L., Morabito, F., Motta, V., Cutrona, G., Matis, S., Recchia, A.G., Gigliotti, V., Gentile, M., et al.(2011). Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia . Epigenetics. 6. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 188-194.

Lucia, E., Recchia, A.G., Gentile, M., Bossio, S., Vigna, E., Mazzone, C., Madeo, A., Morabito, L., Gigliotti, V., Stefano, L.D., et al.(2011). Janus kinase 2 inhibitors in myeloproliferative disorders . Expert Opinion on Investigational Drugs. 20. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 41-59.

Gentile, M., Recchia, A.G., Vigna, E., Mazzone, C., Lucia, E., Gigliotti, V., Bossio, S., Madeo, A., Morabito, L., Servillo, P., et al.(2011). Lenalidomide in the treatment of chronic lymphocytic leukemia . Expert Opinion on Investigational Drugs. 20. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 273-286.

Fabris, S., Scarciolla, O., Morabito, F., Cifarelli, R.A., Dininno, C., Cutrona, G., Matis, S., Recchia, A.G., Gentile, M., Ciceri, G., et al.(2011). Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: A comparative study . Genes Chromosomes and Cancer. 50. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 726-734.

Gentile M, Vigna E, Mazzone C, Lucia E, Recchia A, Morabito L, Bisconte M, Gentile C, Morabito F, Cancer management and research, 2010, vol. 2, pp. 71-81, 2010 .

Morabito, F., Gentile, M., Mazzone, C., Bringhen, S., Vigna, E., Lucia, E., Recchia, A.G., Raimondo, F.D., Musto, P., Palumbo, A.(2010). Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs . European Journal of Haematology. 85. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 181-191.

Vigna, E., De Vivo, A., Gentile, M., Morelli, R., Lucia, E., Mazzone, C., Recchia, A.G., Vianelli, N., Morabito, F.(2010). Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients . Transplant Infectious Disease. 12. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 428-431.

Morabito, F., Cutrona, G., Gentile, M., Loiacono, F., Matis, S., Recchia, A.G., Gigliotti, V., Callea, V., Zupo, S., Ferrarini, M.(2010). More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia . Leukemia Research. 34. (12).

Filice E, Recchia AG, Pellegrino D, Angelone T, Maggiolini M, Cerra MC, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2009, vol. 60, no. 4, pp. 3-10, 2009 .

Recchia AG, Musti AM, Lanzino M, Panno ML, Turano E, Zumpano R, Belfiore A, Andò S, Maggiolini M, The international journal of biochemistry & cell biology, 2009, vol. 41, no. 3, pp. 603-614, 2009 .

Recchia AG, Filice E, Pellegrino D, Dobrina A, Cerra MC, Maggiolini M, Journal of molecular and cellular cardiology, 2009, vol. 46, no. 3, pp. 352-359, 2009 .

Recchia, A.G., Filice, E., Pellegrino, D., Dobrina, A., Cerra, M.C., Maggiolini, M.(2009). Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes . Journal of Molecular and Cellular Cardiology. 46. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 352-359.

Filice, E., Recchia, A.G., Pellegrino, D., Angelone, T., Maggiolini, M., Cerra, M.C.(2009). A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat . Journal of Physiology and Pharmacology. 60. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3-10.

Recchia, A.G., Musti, A.M., Lanzino, M., Panno, M.L., Turano, E., Zumpano, R., Belfiore, A., Andò, S., Maggiolini, M.(2009). A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells . International Journal of Biochemistry and Cell Biology. 41. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 603-614.

Angelone T, Filice E, Quintieri AM, Imbrogno S, Recchia A, Pulerà E, Mannarino C, Pellegrino D, Cerra MC, Acta physiologica (Oxford, England), 2008, vol. 193, no. 3, pp. 229-239, 2008 .

Angelone, T., Filice, E., Quintieri, A.M., Imbrogno, S., Recchia, A., Pulerà, E., Mannarino, C., Pellegrino, D., Cerra, M.C.(2008). β<inf>3</inf>-Adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway . Acta Physiologica. 193. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 229-239.

Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M, Molecular endocrinology (Baltimore, Md.), 2006, vol. 20, no. 3, pp. 631-646, 2006 .

Vivacqua, A., Bonofiglio, D., Recchia, A.G., Musti, A.M., Picard, D., Andò, S., Maggiolini, M.(2006). The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17β-estradiol and hydroxytamoxifen in endometrial cancer cells . Molecular Endocrinology. 20. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 631-646.

Maggiolini M, Recchia AG, Bonofiglio D, Catalano S, Vivacqua A, Carpino A, Rago V, Rossi R, Andò S, Journal of molecular endocrinology, 2005, vol. 35, no. 2, pp. 269-281, 2005 .

Montanaro D, Maggiolini M, Recchia AG, Sirianni R, Aquila S, Barzon L, Fallo F, Andò S, Pezzi V, Journal of molecular endocrinology, 2005, vol. 35, no. 2, pp. 245-256, 2005 .

Montanaro, D., Maggiolini, M., Recchia, A.G., Sirianni, R., Aquila, S., Barzon, L., Fallo, F., Andò, S., Pezzi, V.(2005). Antiestrogens upregulate estrogen receptor β expression and inhibit adrenocortical H295R cell proliferation . Journal of Molecular Endocrinology. 35. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 245-256.

Maggiolini, M., Recchia, A.G., Bonofiglio, D., Catalano, S., Vivacqua, A., Carpino, A., Rago, V., Rossi, R., Andò, S.(2005). The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor α in human breast cancer cells . Journal of Molecular Endocrinology. 35. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 269-281.

Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S, The Journal of biological chemistry, 2004, vol. 279, no. 26, pp. 27008-27016, 2004 .

Maggiolini M, Recchia AG, Carpino A, Vivacqua A, Fasanella G, Rago V, Pezzi V, Briand PA, Picard D, Andò S, Journal of molecular endocrinology, 2004, vol. 32, no. 3, pp. 777-791, 2004 .

Recchia AG, Vivacqua A, Gabriele S, Carpino A, Fasanella G, Rago V, Bonofiglio D, Maggiolini M, Food additives and contaminants, 2004, vol. 21, no. 2, pp. 134-144, 2004 .

Maggiolini, M., Recchia, A.G., Carpino, A., Vivacqua, A., Fasanella, G., Rago, V., Pezzi, V., Briand, P.-A., Picard, D., Andò, S.(2004). Oestrogen receptor β is required for androgen-stimulated proliferation of LNCaP prostate cancer cells . Journal of Molecular Endocrinology. 32. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 777-791.

Recchia, A.G., Vivacqua, A., Gabriele, S., Carpino, A., Fasanella, G., Rago, V., Bonofiglio, D., Maggiolini, M.(2004). Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor α . Food Additives and Contaminants. 21. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 134-144.

Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A.G., Sisci, D., Pezzi, V., Montanaro, D., Musti, A.M., Picard, D., Andò, S.(2004). The G protein-coupled receptor GPR30 Mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells . Journal of Biological Chemistry. 279. (26). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 27008-27016.

Vivacqua A, Recchia AG, Fasanella G, Gabriele S, Carpino A, Rago V, Di Gioia ML, Leggio A, Bonofiglio D, Liguori A, Maggiolini M, Endocrine, 2003, vol. 22, no. 3, pp. 275-284, 2003 .

Vivacqua, A., Recchia, A.G., Fasanella, G., Gabriele, S., Carpino, A., Rago, V., Di Gioia, M.L., Leggio, A., Bonofiglio, D., Liguori, A., et al.(2003). The Food Contaminants Bisphenol A and 4-Nonylphenol Act as Agonists for Estrogen Receptor α in MCF7 Breast Cancer Cells . Endocrine. 22. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 275-284.

Recchia AG, Shear NH, Journal of clinical pharmacology, 1994, vol. 34, no. 1, pp. 68-79, 1994 .

Recchia, A.G., Shear, N.H.(1994). Organization and functioning of an adverse drug reaction clinic . Journal of Clinical Pharmacology. 34. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 68-79.

BOOK

Vigna, E., Recchia, A.G., Gentile, M., Bossio, S., Stefano, L.D., Granata, T., Caruso, N., Pellicanò, M.V., Franzese, S., Fortunato, M.(2013). Leishmaniases: Etiology, epidemiology and clinical hematology . Leishmaniasis: Symptoms, Treatment and Potential Complications. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 29-50.

Gentile, M., Vigna, E., Mazzone, C., Lucia, E., Recchia, A.G., Morabito, L., Bisconte, M.G., Gentile, C., Morabito, F.(2010). Rituximab for the treatment of patients with chronic lymphocytic leukemia . Cancer Management and Research. 2. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 71-81.

level-one heading

PhD, PharmD. Freelance Scientific Editor/Medical Writer with over 20+ years of experience in basic and clinical research

Scientific and Non Scientific writer/Editor

AGReed Biomedica

Lab manager, Research scientist

Fondazione Amelia Scorza/Italian Leukemia Association/Hematology Unit, Annunziata Hospital of Cosenza, Italy

PostdoctoralResearcher

University of Calabria

BSc

University of Toronto

PhD

Università della Calabria Dipartimento di Farmacia e Scienze della Salute e della Nutrizione

PhamD (Farmacia)

Universita della Calabria